Wang Leilei, Zhang Xuefei, Li Dan, Hu Fupin, Wang Minggui, Guo Qinglan, Yang Fan
Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, People's Republic of China.
Infect Drug Resist. 2020 Jan 29;13:247-256. doi: 10.2147/IDR.S240963. eCollection 2020.
To investigate molecular characteristics and antimicrobial susceptibility profiles of clinical isolates of in Shanghai, China.
isolates were collected in a university-affiliated hospital in 2012-2015 and 2017-2018. They were re-identified to species level by 16S rRNA gene and species-specific gene sequencing. Antimicrobial susceptibility testing, screening for metallo-beta-lactamase production, identification of antimicrobial resistance genes and pulsed-field gel electrophoresis (PFGE) were performed.
Among 52 isolates, was the most prevalent species (67.3%), followed by (26.9%). High carriage rates of , and genes were consistent with the poor in vitro activity of most β-lactams including carbapenems. Nevertheless, β-lactamase inhibitors increased susceptibility rates significantly for cefoperazone and piperacillin. Susceptibility rates for minocycline, tigecycline, rifampin and levofloxacin were 100%, 78.8%, 76.9% and 71.2%, respectively. Ser83Ile or Ser83Arg substitution in the DNA gyrase A unit was associated with resistance to fluoroquinolones. MIC/MIC values of vancomycin and linezolid were 16/16 mg/L and 16/32 mg/L, respectively. Molecular typing showed twenty-one different types of PFGE and more than one indistinguishable isolates were observed in each of the eight subtypes.
Tetracyclines, tigecycline, β-lactam/β-lactamase inhibitor combinations, rifampin and fluoroquinolones demonstrated high rates of in vitro activity against clinical isolates of . Both genetic diversity and clonality were observed from this health-care facility. Our report provides potential alternative treatment options for infections.
研究中国上海临床分离株的分子特征及抗菌药物敏感性谱。
2012 - 2015年及2017 - 2018年在一家大学附属医院收集分离株。通过16S rRNA基因和种特异性基因测序将其重新鉴定到种水平。进行了抗菌药物敏感性试验、金属β-内酰胺酶产生情况筛查、抗菌药物耐药基因鉴定及脉冲场凝胶电泳(PFGE)。
在52株分离株中,[具体菌名1]是最常见的菌种(67.3%),其次是[具体菌名2](26.9%)。[具体基因1]、[具体基因2]和[具体基因3]的高携带率与包括碳青霉烯类在内的大多数β-内酰胺类药物体外活性差一致。然而,β-内酰胺酶抑制剂显著提高了头孢哌酮和哌拉西林的敏感性率。米诺环素、替加环素、利福平及左氧氟沙星的敏感性率分别为100%、78.8%、76.9%和71.2%。DNA促旋酶A亚基中的Ser83Ile或Ser83Arg替代与对氟喹诺酮类药物耐药相关。万古霉素和利奈唑胺的MIC/MIC值分别为16/16 mg/L和16/32 mg/L。分子分型显示有21种不同类型的PFGE,在8个亚型中的每一个亚型中均观察到不止一株难以区分的分离株。
四环素类、替加环素、β-内酰胺/β-内酰胺酶抑制剂组合、利福平和氟喹诺酮类药物对[具体菌名]临床分离株显示出较高的体外活性。在该医疗机构中观察到了遗传多样性和克隆性。我们的报告为[具体菌名]感染提供了潜在的替代治疗选择。